Published by
@ShahidNShah
@ShahidNShah
Welcome to the Novel Combination Cancer Immunotherapy Summit -Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond, Is held on 15-17 October 2024 in San Diego, CA.The field of oncology is moving away from targeted monotherapies due to exhibited tumor resistance, low efficiency and off-target effects. Therefore, combination cancer immunotherapies are taking center stage as the next frontier in oncology but challenges remain before they can become the mainstream therapeutic strategy over the current standards of care.From overcoming resistance and relapse to improving patient selection, protocol design, regulatory adherence and route to market, join forces with leading experts in the field such as Merck, Pfizer and Amgen to advance your combination strategies.
[Read on novel-combination](https://novel-combination-immunotherapy-summit.com/take-part/register/)
Continue reading at novel-combination-immunotherapy-summit.com
October 15 to October 16, 2024
Hotel Alfonso XIII, C. San Fernando, 2, Seville, Andalusia, 41004, Spain
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 6, 2024 at 12:08pm